Robert Damoiseaux

Robert Damoiseaux is an Adjunct Professor in the Department of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA) School of Medicine. His research focuses on high-throughput screening technologies, drug repurposing, and molecular mechanisms in pharmacology and virology.

• Key research themes include antiviral drug discovery, cancer metabolism, neurodegenerative disease models, and nanotoxicology.
• He develops innovative platforms like FLECS (Force Loading Element for Cell-based Screening) and hydrogel nanovials for single-cell analysis.

Research Trends: His recent work investigates SARS-CoV-2 antivirals (e.g., GSK-3 inhibitors), MAPKi-resistant melanoma therapies, and mitochondrial regulators in aggressive cancers. The articles span neuroscience, oncology, and virology, emphasizing drug screening, cell signaling, and host-pathogen interactions.

• Scientific Leadership: He co-directs NIH-funded projects on fibrosis models (U01HL153000) and idiopathic pulmonary fibrosis (R01GM114259).
• His collaborations involve multidisciplinary teams across UCLA, UCSD, and Caltech, integrating chemical biology, bioinformatics, and clinical research.